Please enable JavaScript to continue using this application.

Compare $AVXL vs $NERV | Chartloom

Compare

$AVXL vs $NERV

Anavex Life Sciences Corp · Minerva Neurosciences Inc

AVXL

Anavex Life Sciences Corp

NERV

Minerva Neurosciences Inc

Compare $AVXL vs $NERV

Comparing Anavex Life Sciences Corp and Minerva Neurosciences Inc

AVXLAnavex Life Sciences Corp

NERVMinerva Neurosciences Inc

AVXLAnavex Life Sciences Corp

Market cap

$138M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-59.5%

52W performance

-84.9%

FCF yield

-21.2%

NERVMinerva Neurosciences Inc

Market cap

$148M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-18.9%

52W performance

12.4%

FCF yield

-17.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AVXL

NERV

Detailed metrics comparison

AVXL

Anavex Life Sciences Corp

NERV

Minerva Neurosciences Inc

Market Cap

AVXL$138M

NERV$148M

Enterprise Value

AVXL$20M

NERV$184M

Price

AVXL$1.49

NERV$3.18

P/E Ratio

AVXLN/A

NERVN/A

P/S Ratio

AVXL0.00x

NERV0.00x

EV/Sales

AVXL0.00x

NERV0.00x

EV/EBITDA

AVXL0.00x

NERV28.95x

P/B Ratio

AVXL1.50x

NERV19.58x

P/FCF Ratio

AVXLN/A

NERVN/A

EV/FCF

AVXL-0.67x

NERV-7.01x

PEG Ratio

AVXLN/A

NERVN/A

Forward P/E (NTM)

AVXLN/A

NERVN/A

Forward P/S (NTM)

AVXLN/A

NERVN/A

Revenue (TTM)

AVXL$0

NERV$0

Revenue Growth (YoY)

AVXLN/A

NERVN/A

Forward Rev Growth

AVXL377.5%

NERV534.2%

Gross Margin (TTM)

AVXL0.0%

NERV0.0%

Operating Margin (TTM)

AVXL0.0%

NERV0.0%

EBITDA Margin (TTM)

AVXL0.0%

NERV0.0%

Net Margin (TTM)

AVXL0.0%

NERV0.0%

FCF Margin (TTM)

AVXLN/A

NERVN/A

Net Income (TTM)

AVXL$-13M

NERV$-395M

FCF (TTM)

AVXL$-29M

NERV$-26M

EPS (TTM)

AVXL-$0.14

NERV-$5.00

ROE (TTM)

AVXL-1143.0%

NERV-16962.0%

ROA (TTM)

AVXL-1072.0%

NERV-50048.0%

ROIC (TTM)

AVXL-1143.0%

NERV-16962.0%

Cash

AVXL$118M

NERV$25M

Debt

AVXL$0

NERV$60M

Net Cash/Debt

AVXL$118M

NERV$-35M

Current Ratio (TTM)

AVXL15.62x

NERV20.14x

Quick Ratio (TTM)

AVXL15.51x

NERV19.04x

Debt/Equity (TTM)

AVXL0.00x

NERV0.00x

Debt/Assets (TTM)

AVXL0.0%

NERV0.0%

Interest Coverage (TTM)

AVXLN/A

NERVN/A

Net Debt/EBITDA (TTM)

AVXL0.00x

NERV0.00x

Beta

AVXL1.20

NERV0.04

52W Performance

AVXL-84.9%

NERV12.4%

YTD Performance

AVXL-59.5%

NERV-18.9%

% from 52W High

AVXL-85.0%

NERV-74.5%

% from 52W Low

AVXL3.5%

NERV42.1%

Asset Turnover (TTM)

AVXL0.00x

NERV0.00x

FCF Yield (TTM)

AVXL-21.2%

NERV-17.7%

Earnings Yield (TTM)

AVXL-9.4%

NERV-266.7%

Dividend Yield (TTM)

AVXLN/A

NERVN/A

Rule of 40

AVXL0.0

NERV0.0

EV/GP/RG

AVXLN/A

NERVN/A

Ticker research

View AVXL research View NERV research

Metric	AVXL Anavex Life Sciences Corp	NERV Minerva Neurosciences Inc
Market & Valuation
Market Cap	$138M	$148M
Enterprise Value	$20M	$184M
Price	$1.49	$3.18
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	28.95x
P/B Ratio	1.50x	19.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	-7.01x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	377.5%	534.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-13M	$-395M
FCF (TTM)	$-29M	$-26M
EPS (TTM)	-$0.14	-$5.00
ROE (TTM)	-1143.0%	-16962.0%
ROA (TTM)	-1072.0%	-50048.0%
ROIC (TTM)	-1143.0%	-16962.0%
Financial Health
Cash	$118M	$25M
Debt	$0	$60M
Net Cash/Debt	$118M	$-35M
Current Ratio (TTM)	15.62x	20.14x
Quick Ratio (TTM)	15.51x	19.04x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	0.04
52W Performance	-84.9%	12.4%
YTD Performance	-59.5%	-18.9%
% from 52W High	-85.0%	-74.5%
% from 52W Low	3.5%	42.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-21.2%	-17.7%
Earnings Yield (TTM)	-9.4%	-266.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AVXL research	View NERV research

Valuation

P/S Ratio

AVXL

0.00x

NERV

0.00x

EV/FCF

NERV

-7.01x

AVXL

-0.67x

Growth & revenue

Forward Revenue Growth

NERV

534.2%

AVXL

377.5%

Profitability & performance

Gross Margin

AVXL

0.0%

NERV

0.0%

ROE

AVXL

-1143.0%

NERV

-16962.0%

FCF Yield %

NERV

-17.7%

AVXL

-21.2%

52-Week Performance

NERV

12.4%

AVXL

-84.9%

Detailed metrics comparison

AVXL

Anavex Life Sciences Corp

NERV

Minerva Neurosciences Inc

Market Cap

AVXL$138M

NERV$148M

Enterprise Value

AVXL$20M

NERV$184M

Price

AVXL$1.49

NERV$3.18

P/E Ratio

AVXLN/A

NERVN/A

P/S Ratio

AVXL0.00x

NERV0.00x

EV/Sales

AVXL0.00x

NERV0.00x

EV/EBITDA

AVXL0.00x

NERV28.95x

P/B Ratio

AVXL1.50x

NERV19.58x

P/FCF Ratio

AVXLN/A

NERVN/A

EV/FCF

AVXL-0.67x

NERV-7.01x

PEG Ratio

AVXLN/A

NERVN/A

Forward P/E (NTM)

AVXLN/A

NERVN/A

Forward P/S (NTM)

AVXLN/A

NERVN/A

Revenue (TTM)

AVXL$0

NERV$0

Revenue Growth (YoY)

AVXLN/A

NERVN/A

Forward Rev Growth

AVXL377.5%

NERV534.2%

Gross Margin (TTM)

AVXL0.0%

NERV0.0%

Operating Margin (TTM)

AVXL0.0%

NERV0.0%

EBITDA Margin (TTM)

AVXL0.0%

NERV0.0%

Net Margin (TTM)

AVXL0.0%

NERV0.0%

FCF Margin (TTM)

AVXLN/A

NERVN/A

Net Income (TTM)

AVXL$-13M

NERV$-395M

FCF (TTM)

AVXL$-29M

NERV$-26M

EPS (TTM)

AVXL-$0.14

NERV-$5.00

ROE (TTM)

AVXL-1143.0%

NERV-16962.0%

ROA (TTM)

AVXL-1072.0%

NERV-50048.0%

ROIC (TTM)

AVXL-1143.0%

NERV-16962.0%

Cash

AVXL$118M

NERV$25M

Debt

AVXL$0

NERV$60M

Net Cash/Debt

AVXL$118M

NERV$-35M

Current Ratio (TTM)

AVXL15.62x

NERV20.14x

Quick Ratio (TTM)

AVXL15.51x

NERV19.04x

Debt/Equity (TTM)

AVXL0.00x

NERV0.00x

Debt/Assets (TTM)

AVXL0.0%

NERV0.0%

Interest Coverage (TTM)

AVXLN/A

NERVN/A

Net Debt/EBITDA (TTM)

AVXL0.00x

NERV0.00x

Beta

AVXL1.20

NERV0.04

52W Performance

AVXL-84.9%

NERV12.4%

YTD Performance

AVXL-59.5%

NERV-18.9%

% from 52W High

AVXL-85.0%

NERV-74.5%

% from 52W Low

AVXL3.5%

NERV42.1%

Asset Turnover (TTM)

AVXL0.00x

NERV0.00x

FCF Yield (TTM)

AVXL-21.2%

NERV-17.7%

Earnings Yield (TTM)

AVXL-9.4%

NERV-266.7%

Dividend Yield (TTM)

AVXLN/A

NERVN/A

Rule of 40

AVXL0.0

NERV0.0

EV/GP/RG

AVXLN/A

NERVN/A

Ticker research

View AVXL research View NERV research

Metric	AVXL Anavex Life Sciences Corp	NERV Minerva Neurosciences Inc
Market & Valuation
Market Cap	$138M	$148M
Enterprise Value	$20M	$184M
Price	$1.49	$3.18
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	28.95x
P/B Ratio	1.50x	19.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	-7.01x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	377.5%	534.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-13M	$-395M
FCF (TTM)	$-29M	$-26M
EPS (TTM)	-$0.14	-$5.00
ROE (TTM)	-1143.0%	-16962.0%
ROA (TTM)	-1072.0%	-50048.0%
ROIC (TTM)	-1143.0%	-16962.0%
Financial Health
Cash	$118M	$25M
Debt	$0	$60M
Net Cash/Debt	$118M	$-35M
Current Ratio (TTM)	15.62x	20.14x
Quick Ratio (TTM)	15.51x	19.04x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	0.04
52W Performance	-84.9%	12.4%
YTD Performance	-59.5%	-18.9%
% from 52W High	-85.0%	-74.5%
% from 52W Low	3.5%	42.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-21.2%	-17.7%
Earnings Yield (TTM)	-9.4%	-266.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AVXL research	View NERV research